标题
Follicular lymphoma
作者
关键词
-
出版物
Nature Reviews Disease Primers
Volume 5, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-12
DOI
10.1038/s41572-019-0132-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Convergence of risk prediction models in follicular lymphoma
- (2019) Anjali Silva et al. HAEMATOLOGICA
- Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)
- (2019) Franck Morschhauser et al. Lancet Haematology
- Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
- (2019) Daisuke Ennishi et al. Cancer Discovery
- AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
- (2019) John P. Leonard et al. JOURNAL OF CLINICAL ONCOLOGY
- First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study
- (2019) Ian W. Flinn et al. JOURNAL OF CLINICAL ONCOLOGY
- DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
- (2019) Ian W. Flinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Pesticide use and risk of non-Hodgkin lymphoid malignancies in agricultural cohorts from France, Norway and the USA: a pooled analysis from the AGRICOH consortium
- (2019) Maria E Leon et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Germinal center‐derived lymphomas: The darkest side of humoral immunity
- (2019) Coraline Mlynarczyk et al. IMMUNOLOGICAL REVIEWS
- Molecular pathogenesis of germinal center‐derived B cell lymphomas
- (2019) Laura Pasqualucci IMMUNOLOGICAL REVIEWS
- Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population
- (2019) Laura Magnano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Intratumoral Heterogeneity: More Than Just Mutations
- (2019) Kunihiko Hinohara et al. TRENDS IN CELL BIOLOGY
- Non-Hodgkin lymphoma risk and organophosphate and carbamate insecticide use in the north American pooled project
- (2019) Stella Koutros et al. ENVIRONMENT INTERNATIONAL
- Diagnosis and management of follicular lymphoma: A comprehensive review
- (2019) Reyad Dada EUROPEAN JOURNAL OF HAEMATOLOGY
- The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis
- (2019) Michelle A. Mintz et al. IMMUNITY
- Vitamin D status and risk of non-Hodgkin lymphoma: An updated meta-analysis
- (2019) Hye Yin Park et al. PLoS One
- Duodenal-Type Follicular Lymphoma: A Clinicopathologic Review
- (2018) Etan Marks et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study
- (2018) Anne Ségolène Cottereau et al. BLOOD
- Critical influences on the pathogenesis of follicular lymphoma
- (2018) Ralf Küppers et al. BLOOD
- A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
- (2018) Emmanuel Bachy et al. BLOOD
- HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes
- (2018) Sophia S. Wang et al. CANCER RESEARCH
- Microenvironment signaling driving lymphomagenesis
- (2018) Léa Verdière et al. CURRENT OPINION IN HEMATOLOGY
- Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety
- (2018) Wolfgang Hiddemann et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma
- (2018) Stefano Luminari et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study
- (2018) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03
- (2018) Michael MacManus et al. JOURNAL OF CLINICAL ONCOLOGY
- A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
- (2018) Sarah Huet et al. LANCET ONCOLOGY
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
- (2018) Antoine Italiano et al. LANCET ONCOLOGY
- Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
- (2018) Shamzah Araf et al. LEUKEMIA
- A multiprotein supercomplex controlling oncogenic signalling in lymphoma
- (2018) James D. Phelan et al. NATURE
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein
- (2018) Ambrus Gángó et al. VIRCHOWS ARCHIV
- Positive Results for Tazemetostat in Follicular Lymphoma
- (2018) Cancer Discovery
- Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
- (2018) Massimo Federico et al. Lancet Haematology
- Follicular Lymphoma Diagnostic Caveats and Updates
- (2018) Sarah M. Choi et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- An open-label, phase Ib study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma
- (2018) Franck Morschhauser et al. BLOOD
- Initial results of a dose escalation study of a selective and structurally differentiated PI3Kδ inhibitor, ME-401, in relapsed/refractory (R/R) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
- (2018) Jacob Drobnyk Soumerai et al. JOURNAL OF CLINICAL ONCOLOGY
- Human germinal center transcriptional programs are de-synchronized in B cell lymphoma
- (2018) Pierre Milpied et al. NATURE IMMUNOLOGY
- Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
- (2018) Franck Morschhauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Cutaneous Follicle Center Lymphoma
- (2018) Stephanie L. Skala et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Single-cell RNA-Seq of lymphoma cancers reveals malignant B cell types and co-expression of T cell immune checkpoints
- (2018) Noemi Andor et al. BLOOD
- Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG
- (2018) Jessica L. Brady et al. BLOOD
- Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma
- (2018) Brian T. Hill et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
- (2018) Clémentine Sarkozy et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial
- (2018) Judith Trotman et al. LANCET ONCOLOGY
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial
- (2018) Takashi Watanabe et al. Lancet Haematology
- Histological transformation and secondary malignancies in follicular lymphoma
- (2018) Umberto Vitolo et al. Lancet Haematology
- Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
- (2017) Vincent Ribrag et al. HAEMATOLOGICA
- Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach
- (2017) Iris de Weerdt et al. HAEMATOLOGICA
- Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015
- (2017) Randy D. Gascoyne et al. HEMATOLOGICAL ONCOLOGY
- INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMAS
- (2017) F. Morschhauser et al. HEMATOLOGICAL ONCOLOGY
- Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials
- (2017) Qian Shi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
- (2017) Martin Dreyling et al. JOURNAL OF CLINICAL ONCOLOGY
- Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing
- (2017) A Zamò et al. LEUKEMIA
- Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
- (2017) K Karube et al. LEUKEMIA
- Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors
- (2017) Sarah J. Horton et al. NATURE CELL BIOLOGY
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
- (2017) Robert Marcus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma
- (2017) Elisa Oricchio et al. Science Translational Medicine
- Obinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma
- (2017) Sohita Dhillon Targeted Oncology
- The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma
- (2017) Jiyuan Zhang et al. Cancer Discovery
- Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
- (2017) Vincent Ribrag et al. HAEMATOLOGICA
- Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach
- (2017) Iris de Weerdt et al. HAEMATOLOGICA
- Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
- (2016) Matthew J. Maurer et al. AMERICAN JOURNAL OF HEMATOLOGY
- Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era
- (2016) Sayako Yuda et al. ANNALS OF HEMATOLOGY
- Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
- (2016) M. Dreyling et al. ANNALS OF ONCOLOGY
- Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene
- (2016) J. Schmidt et al. BLOOD
- Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma
- (2016) M. Roschewski et al. BLOOD
- Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy
- (2016) V. Jurinovic et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells
- (2016) Michael Boice et al. CELL
- Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
- (2016) Gilles Salles et al. HAEMATOLOGICA
- Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
- (2016) Laurie H Sehn et al. LANCET ONCOLOGY
- Cancer incidence in France over the 1980–2012 period: Hematological malignancies
- (2016) S. Le Guyader-Peyrou et al. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
- (2016) F. Scherer et al. Science Translational Medicine
- CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
- (2016) Yanwen Jiang et al. Cancer Discovery
- Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study
- (2016) Robert Kridel et al. PLOS MEDICINE
- Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
- (2016) Gilles Salles et al. HAEMATOLOGICA
- Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells
- (2015) A. Linley et al. BLOOD
- DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma
- (2015) R. Amin et al. BLOOD
- Familial predisposition and genetic risk factors for lymphoma
- (2015) J. R. Cerhan et al. BLOOD
- Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)
- (2015) N. D. Wagner-Johnston et al. BLOOD
- Cell of origin of transformed follicular lymphoma
- (2015) R. Kridel et al. BLOOD
- Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network
- (2015) A Smith et al. BRITISH JOURNAL OF CANCER
- A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma
- (2015) A. M. Evens et al. CLINICAL CANCER RESEARCH
- Premalignant cell dynamics in indolent B-cell malignancies
- (2015) Pierre Milpied et al. CURRENT OPINION IN HEMATOLOGY
- Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium
- (2015) Andrea ‘t Mannetje et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
- (2015) R. Chen et al. HAEMATOLOGICA
- XIV. The pathology of transformation of indolent B cell lymphomas
- (2015) Randy D. Gascoyne HEMATOLOGICAL ONCOLOGY
- Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
- (2015) Carla Casulo et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)
- (2015) John P. Leonard et al. JOURNAL OF CLINICAL ONCOLOGY
- A retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas
- (2015) Kohei Morita et al. JOURNAL OF CLINICAL PATHOLOGY
- Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
- (2015) Alessandro Pastore et al. LANCET ONCOLOGY
- Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus
- (2015) E Leich et al. LEUKEMIA
- Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
- (2015) Andrea Janikova et al. LEUKEMIA & LYMPHOMA
- Management of adverse events associated with idelalisib treatment: expert panel opinion
- (2015) Steven E. Coutré et al. LEUKEMIA & LYMPHOMA
- Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
- (2015) Jessica Okosun et al. NATURE GENETICS
- Class-switched memory B cells remodel BCRs within secondary germinal centers
- (2015) Louise J McHeyzer-Williams et al. NATURE IMMUNOLOGY
- Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis
- (2015) Jiyuan Zhang et al. NATURE MEDICINE
- The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
- (2015) Ana Ortega-Molina et al. NATURE MEDICINE
- Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation
- (2015) Michael R. Green et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas
- (2015) Murielle Grégoire et al. Oncotarget
- A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
- (2015) R. Chen et al. HAEMATOLOGICA
- Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region
- (2014) Christine F. Skibola et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
- (2014) Mathias Witzens-Harig et al. ANNALS OF HEMATOLOGY
- Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma
- (2014) Diego Villa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis?
- (2014) J. Tellier et al. BLOOD
- Activating STAT6 mutations in follicular lymphoma
- (2014) M. Yildiz et al. BLOOD
- BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma
- (2014) C. Correia et al. BLOOD
- Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
- (2014) I. W. Flinn et al. BLOOD
- Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites
- (2014) E. Mamessier et al. HAEMATOLOGICA
- Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression
- (2014) Stéphanie Sungalee et al. JOURNAL OF CLINICAL INVESTIGATION
- t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma
- (2014) Sandrine Roulland et al. JOURNAL OF CLINICAL ONCOLOGY
- Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
- (2014) Matthew J. Maurer et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402
- (2014) Brad S. Kahl et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy
- (2014) Elisa Oricchio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
- (2014) Kirit M Ardeshna et al. LANCET ONCOLOGY
- Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
- (2014) Nathan H Fowler et al. LANCET ONCOLOGY
- Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma
- (2014) Jagan R. Muppidi et al. NATURE
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics of Follicular Lymphoma Transformation
- (2014) Laura Pasqualucci et al. Cell Reports
- Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma
- (2013) P. Bonetti et al. BLOOD
- Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma
- (2013) M. R. Green et al. BLOOD
- Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000)
- (2013) J. Radford et al. BLOOD
- EZH2 mutations are frequent and represent an early event in follicular lymphoma
- (2013) C. Bodor et al. BLOOD
- EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
- (2013) Wendy Béguelin et al. CANCER CELL
- Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas
- (2013) I. Martin-Guerrero et al. HAEMATOLOGICA
- Early lesions of follicular lymphoma: a genetic perspective
- (2013) E. Mamessier et al. HAEMATOLOGICA
- Germinal Center Centroblasts Transition to a Centrocyte Phenotype According to a Timed Program and Depend on the Dark Zone for Effective Selection
- (2013) Oliver Bannard et al. IMMUNITY
- Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource
- (2013) Brian K. Link et al. JOURNAL OF CLINICAL ONCOLOGY
- Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings
- (2013) Vishakha Sovani et al. JOURNAL OF CLINICAL PATHOLOGY
- Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment
- (2013) S. Rawal et al. JOURNAL OF IMMUNOLOGY
- Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
- (2013) Mathias J Rummel et al. LANCET
- Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma
- (2013) J Schmidt et al. LEUKEMIA
- Emerging issues after the recognition ofin situfollicular lymphoma
- (2013) Antonino Carbone et al. LEUKEMIA & LYMPHOMA
- Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
- (2013) Jessica Okosun et al. NATURE GENETICS
- Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes
- (2012) F. Guilloton et al. BLOOD
- Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas
- (2012) G. D. Victora et al. BLOOD
- Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
- (2012) C. Visco et al. HAEMATOLOGICA
- Roles of BCL6 in normal and transformed germinal center B cells
- (2012) Katia Basso et al. IMMUNOLOGICAL REVIEWS
- Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study
- (2012) Jonathan W. Friedberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis
- (2012) Frédéric Mourcin et al. Frontiers in Immunology
- How I treat: diagnosing and managing "in situ" lymphoma
- (2011) A. Carbone et al. BLOOD
- Lymphoid Malignancies in U.S. Asians: Incidence Rate Differences by Birthplace and Acculturation
- (2011) C. A. Clarke et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- In situ follicular lymphoma: pathologic characteristics and diagnostic features
- (2011) Antonino Carbone et al. HEMATOLOGICAL ONCOLOGY
- p53-dependent Induction ofPVT1and miR-1204
- (2011) Anthony M. Barsotti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
- (2011) Mark Kirschbaum et al. JOURNAL OF CLINICAL ONCOLOGY
- High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis
- (2011) E Launay et al. LEUKEMIA
- Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells
- (2011) P Amé-Thomas et al. LEUKEMIA
- In situfollicular lymphoma associated with nonlymphoid malignancies
- (2011) Antonino Carbone et al. LEUKEMIA & LYMPHOMA
- Inactivating mutations of acetyltransferase genes in B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response
- (2011) K. A. Pape et al. SCIENCE
- Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation
- (2011) Oliver Weigert et al. Cancer Discovery
- Elevated circulating t(14;18) translocation levels prior to diagnosis of follicular lymphoma
- (2010) K. L. Bretherick et al. BLOOD
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
- (2010) M. Sant et al. BLOOD
- Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis
- (2010) K.-J. J. Cheung et al. CANCER RESEARCH
- Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases
- (2010) Santiago Montes-Moreno et al. HISTOPATHOLOGY
- Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1
- (2010) John P. Graham et al. IMMUNOLOGICAL REVIEWS
- Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98
- (2010) Giovanni Martinelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
- (2010) Gilles Salles et al. LANCET
- Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis
- (2010) C Pangault et al. LEUKEMIA
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone
- (2009) E. Carlotti et al. BLOOD
- Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
- (2009) E. Leich et al. BLOOD
- TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
- (2009) K. Honma et al. BLOOD
- The Germinal centre-derived lymphomas seen through their cellular microenvironment
- (2009) Antonino Carbone et al. BRITISH JOURNAL OF HAEMATOLOGY
- Highly increased familial risks for specific lymphoma subtypes
- (2009) Lynn R. Goldin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
- (2009) Jonathan W. Friedberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
- (2009) Massimo Federico et al. JOURNAL OF CLINICAL ONCOLOGY
- Agricultural pesticide exposure and the molecular connection to lymphomagenesis
- (2009) Julie Agopian et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Frequent inactivation of A20 in B-cell lymphomas
- (2009) Motohiro Kato et al. NATURE
- Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma
- (2009) Christine F Skibola et al. NATURE GENETICS
- Multiple layers of B cell memory with different effector functions
- (2009) Ismail Dogan et al. NATURE IMMUNOLOGY
- Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals
- (2008) Frank Schüler et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
- (2008) Robert Marcus et al. JOURNAL OF CLINICAL ONCOLOGY
- Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
- (2008) Abdulwahab J. Al-Tourah et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started